Skip to content
OpenCapital
Get started

MoonLake Immunotherapeutics MLTX Portugal — Number of operating leases

Similar metrics at other companies

Hillman Solutions Corp. logo
HLMNLessee, Operating Lease, Number Of Leases
2—
Tarsus Pharmaceuticals, Inc. logo
TARSNumber of leases
2-66.7%
Lazard logo
LAZNumber of leases
2—
AZZ logo
AZZNumber of operating leases
145-0.7%
Upwork Inc. logo
UPWKLisbon, Portugal — Operating lease asset
$3.6M—
Upwork Inc. logo
UPWKLisbon, Portugal — Operating Lease, Liability
$3.5M—

Other financials

Income statement

See full
Operating income-$70.0M-47.5%
Net income-$69.7M-74.5%
EPS (diluted)-$0.98-55.6%

Balance sheet

See full
Cash & equivalents$298.5M+9.9%
Total debt$100.8M+33.3%
Total equity$254.0M-37.7%
Total assets$400.4M-21.7%

Cash flow

See full
Operating cash flow-$66.3M-73.8%
CapEx--100%
Free cash flow-$66.3M-73.6%

Valuation

See full
Market cap$1.49B-45.9%
Enterprise value$1.29B-50.0%

Returns & leverage

See full
Return on equity-77.7%-221pp
Debt / equity0.4×+0.2×
Current ratio8.6×-12.5×

Where this comes from

Reported directly by MoonLake Immunotherapeutics in its filing.

Tagged under the XBRL concept mnlk:NumberOfOperatingLeases.

The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about MoonLake Immunotherapeutics's portugal — number of operating leases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MoonLake Immunotherapeutics's portugal — number of operating leases?
MoonLake Immunotherapeutics (MLTX) reported portugal — number of operating leases of 2 in Q1 2026.
How has MoonLake Immunotherapeutics's portugal — number of operating leases changed year-over-year?
MoonLake Immunotherapeutics's portugal — number of operating leases increased by 300.0% year-over-year, from 0.5 to 2.
What does portugal — number of operating leases mean?
This metric represents the total count of active operating lease agreements held by the company within the specified geographic region. It provides insight into the company's physical footprint and commitment to leased infrastructure in that market. Monitoring this figure helps investors understand the scale of operations and the associated fixed-cost obligations in a particular territory.